CHEK1 and medulloblastoma: Recently, studies combining CHK1 inhibitors with a cytotoxic agent have shown promising results in adult and pediatric solid tumors, however, the role of inhibiting CHK1 in the context of medulloblastoma is not well characterized [22, 25].